Form 6K Can-Fite BioPharma Ltd. For: 17 March

Standard risk disclosure: trading financial instruments and cryptocurrencies involves high risks, including the potential loss of some or all invested capital, and crypto prices are described as extremely volatile and sensitive to external events. Fusion Media notes site data may not be real-time or accurate, disclaims liability for trading losses, and prohibits unauthorized use or distribution of the data.

Analysis

Regulatory tightening and elevated caution among retail investors are acting as a force-multiplier that concentrates flows into regulated on‑ and off‑ramps (custody, broker‑dealers, ETFs) and away from fragmented offshore venues and many DeFi lending pools. The economics: higher compliance fixed costs raise effective barriers to entry, allowing incumbents to price for scale — expect 3–12 months of margin expansion for custody/exchange revenue streams even if spot crypto prices remain flat.

A near-term second‑order effect is in the derivatives market: forced de‑risking and capital reallocation shrink open interest and compress futures basis, creating persistent negative or inverted funding that can last days‑to‑weeks and produce asymmetric buying opportunities for liquidity providers. Watch funding rates crossing ±0.05%/day and a >20% drop in aggregate open interest as tactical triggers for mean‑reversion trades.

Longer horizon: clearer regulation (stablecoin rules or a path for spot ETFs) is likely to channel institutional pools into regulated vehicles, lowering counterparty risk and reducing realized volatility over years — a structurally positive outcome for listed financial intermediaries. The main tail risks are abrupt enforcement actions or a major custodian failure that would reverse flows quickly; a credible, imminent policy decision (weeks–months) from major regulators is the key catalyst to watch.

Key Decisions for Investors

• Buy COIN (Coinbase) on a 10–20% pullback versus the NASDAQ within 3 months; size 1–2% NAV and hedge ~50% BTC delta with short BTC futures to isolate fee/revenue capture. Target: 25–35% upside in 6–12 months if regulatory flows concentrate; stop‑loss: 10% absolute.
• Pair trade — long COIN / short MSTR 1:1 notional for a 6‑month horizon to capture exchange revenue growth vs leveraged BTC beta. Target relative outperformance 20–30%; risk: large BTC moves (>40% in 30 days) increase noise, so reduce position if BTC volatility spikes.
• Arbitrage: buy GBTC (or similar closed‑end/discounted vehicles) when discount to NAV >15% and short equivalent BTC futures to lock in convergence optionality over 1–6 months. Expected carry 5–15% annualized if conversion/liquidity event occurs; tail risk: discount widens further during systemic stress.
• Tactical hedge: purchase 4‑week BTC puts 10–12% OTM sized to cover ~30% of crypto directional exposure whenever funding rates exceed +0.05%/day or open interest drops >25% in a week. Budget ~0.5–1% NAV per month for this insurance — economical versus paying for uncontrolled deleveraging.